Literature DB >> 10037569

Comparison of different biomaterials for glaucoma drainage devices.

R S Ayyala1, L E Harman, B Michelini-Norris, L E Ondrovic, E Haller, C E Margo, S X Stevens.   

Abstract

OBJECTIVES: To compare the inflammatory reaction associated with the insertion of silicone and polypropylene endplates and endplates made of a new biocompatible polymer, Vivathane, in the rabbit subconjunctival space.
METHODS: Similar-sized endplates made of 3 different biomaterials were sutured to the sclera in the superotemporal quadrant of the rabbit eye. Thirty eyes of 15 albino New Zealand rabbits were randomly assigned to the 3 groups. Conjunctival vascular hyperemia was graded in a masked fashion among groups. At the end of 3 weeks, the enucleated eyes were examined histologically and using scanning electron microscopy.
RESULTS: Polypropylene and Vivathane were associated with significantly more inflammation in clinical observations and based on histological grading. Silicone was associated with the least amount of inflammation. Three polypropylene and 1 Vivathane plate were extruded between the second and third week.
CONCLUSIONS: Silicone is the most inert of the 3 materials tested. Inflammation associated with biomaterials may contribute to the failure of the glaucoma drainage devices. CLINICAL RELEVANCE: Bleb inflammation may be related to the biomaterial being used as the endplate. Endplates should be handled carefully during surgery to avoid creating rough spots.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037569     DOI: 10.1001/archopht.117.2.233

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  25 in total

1.  Ex-PRESS implant.

Authors:  A Mermoud
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

2.  Injectable Polymeric Cytokine-Binding Nanowires Are Effective Tissue-Specific Immunomodulators.

Authors:  Colin R Zamecnik; Margaret M Lowe; David M Patterson; Michael D Rosenblum; Tejal A Desai
Journal:  ACS Nano       Date:  2017-11-15       Impact factor: 15.881

3.  [Pathophysiology of fibrotic encapsulation of episcleral glaucoma drainage implants: modification for improvement of clinical results].

Authors:  L Choritz; M Wegner; R Förch; U Jonas; H Thieme
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

4.  Use of subconjunctival injections of 5-fluorouracil to rescue and prolong intraocular pressure reduction for a failing Ahmed glaucoma implant.

Authors:  Kevin Kaplowitz; Sarah Khodadadeh; Samantha Wang; Daniel Lee; James C Tsai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-08       Impact factor: 3.117

Review 5.  Current status of epibulbar anti-glaucoma drainage devices in glaucoma surgery.

Authors:  Hagen Thieme
Journal:  Dtsch Arztebl Int       Date:  2012-10-05       Impact factor: 5.594

Review 6.  [Glaucoma drainage devices].

Authors:  H Thieme
Journal:  Ophthalmologe       Date:  2009-12       Impact factor: 1.059

7.  [Tube versus trabeculectomy study].

Authors:  H Thieme; L Choritz; C Schuart; T Wecke
Journal:  Ophthalmologe       Date:  2013-08       Impact factor: 1.059

8.  Polypropylene vs silicone Ahmed valve with adjunctive mitomycin C in paediatric age group: a prospective controlled study.

Authors:  Y El Sayed; A Awadein
Journal:  Eye (Lond)       Date:  2013-04-12       Impact factor: 3.775

9.  Effect of Two Novel Sustained-Release Drug Delivery Systems on Bleb Fibrosis: An In Vivo Glaucoma Drainage Device Study in a Rabbit Model.

Authors:  Evan D Schoenberg; Diane A Blake; F Beau Swann; Andrew W Parlin; David Zurakowski; Curtis E Margo; Thiruselvam Ponnusamy; Vijay T John; Ramesh S Ayyala
Journal:  Transl Vis Sci Technol       Date:  2015-05-22       Impact factor: 3.283

10.  Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts--potential use in drug-eluting glaucoma drainage devices.

Authors:  Lars Choritz; Jochen Grub; Maria Wegner; Norbert Pfeiffer; Hagen Thieme
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-07       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.